相似文献
1
Peptide HIV-1 integrase inhibitors from HIV-1 gene products.
J Med Chem. 2010 Jul 22;53(14):5356-60. doi: 10.1021/jm1003528.
2
Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.
Bioorg Med Chem. 2010 Sep 15;18(18):6771-5. doi: 10.1016/j.bmc.2010.07.050. Epub 2010 Jul 25.
3
Cell-permeable stapled peptides based on HIV-1 integrase inhibitors derived from HIV-1 gene products.
ACS Chem Biol. 2013 Oct 18;8(10):2235-44. doi: 10.1021/cb400495h. Epub 2013 Aug 15.
4
Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
J Mol Biol. 2007 Jun 22;369(5):1230-43. doi: 10.1016/j.jmb.2007.03.073. Epub 2007 Apr 1.
5
HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R Sequence.
Molecules. 2018 Jul 26;23(8):1858. doi: 10.3390/molecules23081858.
6
Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.
J Biol Chem. 2005 Jun 10;280(23):21987-96. doi: 10.1074/jbc.M414679200. Epub 2005 Mar 23.
7
Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity.
J Antimicrob Chemother. 2014 Oct;69(10):2733-40. doi: 10.1093/jac/dku199. Epub 2014 Jun 10.
8
Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles.
Antiviral Res. 2004 Oct;64(1):35-45. doi: 10.1016/j.antiviral.2004.04.007.
9
Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein.
Bioorg Med Chem. 2010 Dec 1;18(23):8388-95. doi: 10.1016/j.bmc.2010.09.046. Epub 2010 Oct 1.
10
Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization.
Antimicrob Agents Chemother. 2012 Aug;56(8):4365-74. doi: 10.1128/AAC.00717-12. Epub 2012 Jun 4.
引用本文的文献
1
Structure-Guided Antiviral Peptides Identification Targeting the HIV-1 Integrase.
ACS Phys Chem Au. 2024 Jul 5;4(5):464-475. doi: 10.1021/acsphyschemau.4c00006. eCollection 2024 Sep 25.
2
Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins.
RSC Adv. 2023 Jan 12;13(3):2156-2167. doi: 10.1039/d2ra06837k. eCollection 2023 Jan 6.
3
Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid Proteins.
Biomolecules. 2021 Feb 3;11(2):208. doi: 10.3390/biom11020208.
4
HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R Sequence.
Molecules. 2018 Jul 26;23(8):1858. doi: 10.3390/molecules23081858.
5
Development of peptide inhibitors of HIV transmission.
Bioact Mater. 2016 Sep 16;1(2):109-121. doi: 10.1016/j.bioactmat.2016.09.004. eCollection 2016 Dec.
6
Identification of interaction between HIV-1 glycoprotein 41 and integrase.
Virol Sin. 2016 Oct;31(5):415-424. doi: 10.1007/s12250-016-3820-7. Epub 2016 Sep 26.
7
A Triazinone Derivative Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity.
ChemMedChem. 2016 Oct 19;11(20):2320-2326. doi: 10.1002/cmdc.201600375. Epub 2016 Sep 16.
8
HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.
Microbiol Mol Biol Rev. 2016 Jun 29;80(3):679-731. doi: 10.1128/MMBR.00065-15. Print 2016 Sep.
9
Inhibiting the HIV integration process: past, present, and the future.
J Med Chem. 2014 Feb 13;57(3):539-66. doi: 10.1021/jm400674a. Epub 2013 Sep 25.
10
Cell-permeable stapled peptides based on HIV-1 integrase inhibitors derived from HIV-1 gene products.
ACS Chem Biol. 2013 Oct 18;8(10):2235-44. doi: 10.1021/cb400495h. Epub 2013 Aug 15.
本文引用的文献
1
Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
J Mol Biol. 2007 Jun 22;369(5):1230-43. doi: 10.1016/j.jmb.2007.03.073. Epub 2007 Apr 1.
2
Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium.
Proc Natl Acad Sci U S A. 2007 May 15;104(20):8316-21. doi: 10.1073/pnas.0700781104. Epub 2007 May 8.
3
Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.
Arch Biochem Biophys. 2007 Feb 15;458(2):202-12. doi: 10.1016/j.abb.2006.12.007. Epub 2006 Dec 28.
4
Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.
J Med Chem. 2006 Jul 27;49(15):4477-86. doi: 10.1021/jm060307u.
5
Preferential inhibition of the magnesium-dependent strand transfer reaction of HIV-1 integrase by alpha-hydroxytropolones.
Mol Pharmacol. 2006 Apr;69(4):1454-60. doi: 10.1124/mol.105.020321. Epub 2006 Jan 17.
6
A novel small molecular weight compound with a carbazole structure that demonstrates potent human immunodeficiency virus type-1 integrase inhibitory activity.
Antivir Chem Chemother. 2005;16(6):363-73. doi: 10.1177/095632020501600603.
7
Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design.
J Comput Aided Mol Des. 2004 Dec;18(12):739-60. doi: 10.1007/s10822-005-0365-5. Epub 2005 Jun 27.
8
Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.
J Biol Chem. 2005 Jun 10;280(23):21987-96. doi: 10.1074/jbc.M414679200. Epub 2005 Mar 23.
9
A capillary electrophoretic assay for ribonuclease H activity.
Anal Biochem. 2004 Aug 15;331(2):296-302. doi: 10.1016/j.ab.2004.05.017.
10
Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins.
J Virol. 2004 May;78(10):5056-67. doi: 10.1128/jvi.78.10.5056-5067.2004.
Zotero 插件